COVID-19 Impact on Pfizer's Ad Spending and Restaurant Industry Challenges

The chapter explores Pfizer's ad spending during COVID-19, comparisons to competitors like Moderna and Johnson & Johnson, and legal challenges faced by Pfizer. It transitions to discussing the struggles of U.S. restaurants due to rising food prices, remote work trends, and reduced urban foot traffic. Additionally, the chapter analyzes Uber Eats revenue post-COVID-19 and highlights the contrast between increased food delivery profits and the decline in traditional restaurant sales during the pandemic.